ImmuPharma (LON:IMM) Stock Price Down 10.1% – What’s Next?

ImmuPharma plc (LON:IMM) shares dropped 10.1% during trading on Tuesday . The stock traded as low as GBX 3.22 ($0.04) and last traded at GBX 3.37 ($0.04). Approximately 8,361,791 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 27,776,645 shares. The stock had previously closed at GBX 3.75 ($0.05).

ImmuPharma Stock Performance

The stock has a 50-day moving average of GBX 1.54 and a 200 day moving average of GBX 1.68. The firm has a market capitalization of £10.24 million, a P/E ratio of -246.00 and a beta of 1.53.

About ImmuPharma

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.